{"id":39,"date":"2024-04-04T03:43:29","date_gmt":"2024-04-04T00:43:29","guid":{"rendered":"https:\/\/sisu.ut.ee\/hiv\/publications-0\/"},"modified":"2024-04-12T13:42:12","modified_gmt":"2024-04-12T10:42:12","slug":"publications-0","status":"publish","type":"page","link":"https:\/\/sisu.ut.ee\/hiv\/publications-0\/?lang=en","title":{"rendered":"Publications"},"content":{"rendered":"

2017<\/strong><\/span><\/p>\n

Huik, Kristi; Soodla, Pilleriin; Pauskar, Merit; Rajasaar, Heli; J\u00f5geda, Ene-Ly; Eveli, Kallas; Avi, Radko; Lutsar, Irja\u00a0The evalation of two HIV-1 incidence assays in subjects infected with\u00a0non-B subtype viruses.\u00a0ECCMID<\/a>\u00a02017<\/span><\/p>\n

\n

2016<\/strong><\/span><\/p>\n

Laisaar, Kaja-Triin; Raag, Mait; Lutsar, Irja; Uusk\u00fcla, Anneli\u00a0<\/a>People living with HIV in Estonia: engagement in HIV care in 2013.\u00a0<\/a>Euro Surveill.<\/a>\u00a0<\/a>2016<\/a>\u00a0<\/a>Oct 27;21(43)<\/a><\/span><\/p>\n

Avi, Radko; Pauskar, Merit; Karki, T\u00f5nis; Kallas, Eveli; J\u00f5geda, Ene-Ly; Margus, T\u00f5nu; Huik, Kristi; Lutsar, Irja (2016).\u00a0Prevalence of drug resistance mutations in HAART patients infected\u00a0with HIV-1 CRF06_cpx in Estonia.\u00a0Journal of Medical Virology, 88 (3), 448\u2212454, 10.1002\/jmv.24361.<\/a><\/span><\/p>\n

Kallas, Eveli; Huik, Kristi; T\u00fcrk, Silver; Pauskar, Merit; J\u00f5geda, Ene-Ly; \u0160unina, Marina; Karki, T\u00f5nis; Des Jarlais, Don; Uusk\u00fcla, Anneli; Avi, Radko; Lutsar, Irja (2016).\u00a0<\/a>T Cell Distribution in Relation to HIV\/HBV\/HCV Coinfections and Intravenous Drug Use.\u00a0<\/a>Viral immunology, 0\u22120.<\/a><\/span><\/p>\n

Huik, Kristi; Avi, Radko; Pauskar, Merit; Kallas, Eveli; J\u00f5geda, Ene-Ly; Karki, T\u00f5nis; R\u00fc\u00fctel, Kristi; Talu, Ave; Abel-Ollo, Katri; Uusk\u00fcla, Anneli; Carrillo, Andrew; Ahuja, Sunil K; He, Weijing; Lutsar, Irja (2016).\u00a0A CCL5 Haplotype Is Associated with Low Seropositivity Rate of HCV Infection in People Who Inject Drugs.\u00a0PloS one, 11 (6), e0156850\u2212e0156850, 10.1371\/journal.pone.0156850.<\/a><\/span><\/p>\n

J\u00f5geda, Ene-Ly; Avi, Radko; Pauskar, Merit; Kallas, Eveli; Karki, T\u00f5nis; Des Jarlais, Don; Uusk\u00fcla, Anneli; Lutsar, Irja; Huik, Kristi (2016).\u00a0Human T-lymphotropic virus types 1 and 2 are rare among intravenous drug users in Eastern Europe.\u00a0Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases, 43, 83\u221285, 10.1016\/j.meegid.2016.05.022.<\/a><\/span><\/p>\n

\n

2015<\/strong><\/span><\/p>\n

Kallas, Eveli; Huik, Kristi; T\u00fcrk, Silver; Pauskar, Merit; J\u00f5geda, Ene-Ly; \u0160unina, Marina; Karki, T\u00f5nis; Des Jarlais, Don; Uusk\u00fcla, Anneli; Avi, Radko; Lutsar, Irja (2015).\u00a0Differences in T cell distribution and CCR5 expression in HIV-positive and HIV-exposed seronegative persons who inject drugs.\u00a0Medical microbiology and immunology, 1\u22129, 10.1007\/s00430-015-0444-8.<\/a><\/span><\/p>\n

Rhee, S.-Y.; Blanco, J.L.; Jordan, M.R.; Taylor, J.; Lemey, P.; Varghese, V.; Hamers, R.L.; Bertagnolio, S.; de Wit, T.F.R.; Aghokeng, A.F.; Albert, J.; Avi, R.; Avila-Rios, S.; Bessong, P.O.; Brooks, J.I.; Boucher, C.A.B.; Brumme, Z.L.; Busch, M.P.; Bussmann, H.; Chaix, M.-L.; Chin, B.S.; D\u00e2\u0080\u0099Aquin, T.T.; De Gascun, C.F.; Derache, A.; Descamps, D.; Deshpande, A.K.; Djoko, C.F.; Eshleman, S.H.; Fleury, H.; Frange, P.; Fujisaki, S.; Harrigan, P.R.; Hattori, J.; Holguin, A.; Hunt, G.M.; Ichimura, H.; Kaleebu, P.; Katzenstein, D.; Kiertiburanakul, S.; Kim, J.H.; Kim, S.S.; Li, Y.; Lutsar, I.; Morris, L.; Ndembi, N.; NG, K.P.; Paranjape, R.S.; Peeters, M.; Poljak, M.; Price, M.A.; Ragonnet-Cronin, M.L.; Reyes-Ter\u00c3\u00a1n, G.; Rolland, M.; Sirivichayakul, S.; Smith, D.M.; Soares, M.A.; Soriano, V.V.; Ssemwanga, D.; Stanojevic, M.; Stefani, M.A.; Sugiura, W.; Sungkanuparph, S.; Tanuri, A.; Tee, K.K.; Truong, H.-H.M.; van de Vijver, D.A.M.C.; Vidal, N.; Yang, C.; Yang, R.; Yebra, G.; Ioannidis, J.P.A.; Vandamme, A.-M.; Shafer, R.W. (2015).\u00a0Geographic and Temporal Trends in the Molecular Epidemiology and Genetic Mechanisms of Transmitted HIV-1 Drug Resistance: An Individual-Patient- and Sequence-Level Meta-Analysis (PLoS Medicine).\u00a0PLOS Medicine, 12(4), 1001810<\/span><\/p>\n

\u00a0Soodla P, Rajasaar H, Avi R, Zilmer K, Kink K, Novikova L, Huik K, Maimets M, Lutsar I.\u00a0Design and structure of the Estonian HIV Cohort Study (E-HIV).Infect Dis (Lond). 2015;47(11):768-75. doi: 10.3109\/23744235.2015.1061203<\/a>.\u00a0<\/span><\/p>\n

Kallas, E.; Huik, K.; Pauskar, M.; J\u00f5geda,E.-L.; Karki, T.; Des Jarlais, D.; Uusk\u00fcla, A.; Avi, R.; Lutsar, I. (2015).\u00a0Influence of interleukin 10 polymorphisms -592 and -1082 to the HIV, HBV and HCV serostatus among intravenous drug users.\u00a0Infection, genetics and evolution, 30, 175 \u2013 180.<\/a><\/span><\/p>\n

\n

2014<\/strong><\/span><\/p>\n

Avi, R; Huik, K; Pauskar, M; Ustina, V; Karki,T; Kallas, E; J\u00f5geda, EL; Krispin, T; Lutsar, I (2014).\u00a0Transmitted drug resistance is still low in newly diagnosed human immunodeficiency virus type 1 CRF06_cpx-infected patients in Estonia in 2010.\u00a0AidsResearch and Human Retroviruses, 30(3), 278 \u2013 283.<\/a><\/span><\/p>\n

Huik, K.; Avi, R.; Uibopuu, H.; Pauskar, M.; Margus, T.; Karki, T.; Krispin, T.; Kool, P.; R\u00fc\u00fctel, K.; Talu, A.; Abel-Ollo, K.; Uusk\u00fcla, A.; Carrillo, AQ.; He, W.; Ahuja, SK.; Lutsar, I. (2014).\u00a0Association between HIV-1 tropism and CCR5 human haplotype E in a Caucasian population.\u00a0Jaids-Journal of Acquired Immune Deficiency Syndromes, 66(3), 239 \u2013 244.<\/a><\/span><\/p>\n

\n

2013<\/strong><\/span><\/p>\n

Huik, K; Avi, R; Pauskar, M; Kallas, E;J\u00f5geda, EL; Karki, T; Marsh, K; Des Jarlais, D; Uusk\u00fcla, A; Lutsar, I (2013).\u00a0Association between TLR3 rs3775291 and resistance to HIV among highly exposed Caucasian intravenous drug users. Infection,genetics and evolution, 20, 78 \u2013 82.<\/a><\/span><\/p>\n

Huik, K; Avi, R; Carrillo, A; Harper, N;Pauskar, M; Sadam, M; Karki, T; Krispin, T; He, W; Lutsar, I (2013).\u00a0CCR5 Haplotypes Influence HCV Serostatus in Caucasian Intravenous Drug Users.\u00a0PLoS ONE, 8(7), e70561<\/a><\/span><\/p>\n

Lodi, S; del Amo, J; d\u2019Arminio Monforte, A;Abgrall, S; Sabin, C; Morrison, C; Furrer, H; Muga, R; Porter, K; Girardi, E(2013).\u00a0Risk of tuberculosis following HIV seroconversion in high-income countries.\u00a0Thorax, 68(3), 207 -213.<\/a><\/span><\/p>\n

Touloumi, G; Pantazis, N; Pillay, D;Paraskevis, D; Chaix, ML; Bucher, HC; Kucherer, C; Zangerle, R; Kran, AM;Porter, K (2013).\u00a0Impact of HIV-1 subtype on CD4 count at HIV seroconversion, rate of decline, and viral load set point in European seroconverter cohorts.\u00a0Clinical Infectious Diseases, 56(6), 888 -897.<\/a><\/span><\/p>\n

van der Helm, J; Geskus, R; Sabin, C; Meyer,L; Del Amo, J; Chene, G; Dorrucci, M; Muga, R; Porter, K; Prins, M (2013).\u00a0Effect of HCV infection on cause-specific mortality after HIV seroconversion, before and after.\u00a0Gastroenterology,144(4), 751 \u2013 760.<\/a><\/span><\/p>\n

\n

2012<\/strong><\/span><\/p>\n

Huang, X.; Lodi, S.; Fox, Z.; Li, W.; Phillips,A.; Porter, K.; Lutsar, I.; Kelleher, A.; Li, N.; Xu, X.; Wu, H.; Johnson, AM.(2012).\u00a0Rate of CD4 decline and HIV-RNA change following HIV Seroconversion inmen who have sex with men: a comparison between the Beijing PRIMO and CASCADE cohorts. Jaids-Journal of Acquired Immune Deficiency Syndromes<\/a><\/span><\/p>\n

Jarrin, I; Pantazis, N; Gill, MJ; Geskus, R;Perez-Hoyos, S; Meyer, L; Prins, M; Touloumi, G; Johnson, A; Hamouda, O; deOlalla, PG; Porter, K; del Amo, J (2012).\u00a0Uptake of combination antiretroviral therapy and HIV disease progression according to geographical origin in seroconverters in Europe, Canada, and Australia.\u00a0Clinical Infectious Diseases, 54(1), 111 \u2013 118.<\/a><\/span><\/p>\n

\n

2011<\/strong><\/span><\/p>\n

Avi, R; Huik, K; Pauskar, M; Ustina, V; Karki,T; Krispin, T; Ainsalu, K; Paap, P; Schmidt, J; Nikitina, N; Lutsar, I. (2011).EmergingTransmitted Drug Resistance in Treatment Naive Human Immunodeficiency Virus \u2013 1CRF06_cpx Infected Patients in Estonia.\u00a0Scandinavian Journal of Infectious Diseases, 43(2), 122 \u2013 128.<\/a><\/span><\/p>\n

Jaffe, HW; De Stavola, BL; Carpenter, LM;Porter, K; Cox, DR (2011).\u00a0Immune reconstitution and risk of Kaposi sarcoma and non-Hodgkin lymphoma in HIV-infected adults.\u00a0AIDS, 25(11), 1395 \u2013 1403.<\/a><\/span><\/p>\n

Laisaar, K.-T.; Avi, R.; Dehovitz, J.;Uusk\u00fcla, A. (2011).\u00a0Estonia at the Threshold of the Fourth Decade of the AIDS Era inEurope.\u00a0Aids Research and HumanRetroviruses, 27(8), 841 \u2013 851.<\/a><\/span><\/p>\n

Lutsar, Irja (2011).\u00a0Writing Committee for the CASCADE Collaboration. Timing of HAART initiation and clinical outcomes in human immunodeficiency virus type 1 seroconverters.\u00a0Archives of Internal Medicine, 171(17), 1560 \u2013 1569.<\/a><\/p>\n

Mussini, C; Cossarizza, A; Sabin, C; Babiker, A; De Luca, A; Bucher, HC; Fisher, M; Rezza, G; Porter, K; Dorrucci, M (2011).\u00a0Decline of CD4(+) T-cell count before start of therapy and immunological response to treatment in antiretroviral-naive individuals.\u00a0AIDS, 25(8), 1041 \u2013 1049.<\/a><\/span><\/p>\n

van der Helm, JJ; Prins, M; del Amo, J;Bucher, HC; Chene, G; Dorrucci, M; Gill, J; Hamouda, O; Sannes, M; Porter, K;Geskus, RB (2011).\u00a0The hepatitis C epidemic among HIV-positive MSM: incidence estimatesfrom 1990 to 2007.\u00a0AIDS, 25(8),1083 \u2013 1091.<\/a><\/span><\/p>\n

\n

2010<\/strong><\/span><\/p>\n

Huik, K.; Sadam, M.; Karki, T.; Avi, R.;Krispin, T.; Paap, P.; R\u00fc\u00fctel, K.; Uusk\u00fcla, A.; Talu, A.; Abel-Ollo, K.;Lutsar, I. (2010).\u00a0CCL3L1 copy number is a strong genetic determinant of HIV seropositivity in Caucasian intravenous drug users.\u00a0The Journal of Infectious Diseases, 730 -739.<\/a><\/span><\/p>\n

Avi, R.; Huik, K.; Sadam, M.; Karki, T.;Krispin, T.; Ainsalu, K.; Paap, P.; Schmidt, J.; Nikitina, N.; Lutsar, I.(2010).\u00a0Characterization of Integrase Region Polymorphisms in HIV-1 CRF06_cpxViruses in Treatment Na\u00efve Patients in Estonia.\u00a0Aids Research and Human Retroviruses, 26(10), 1109 \u2013 1113.<\/a><\/span><\/p>\n

\n

2009<\/strong><\/span><\/p>\n

Avi, R; Huik, K; Sadam, M; Karki, T; Krispin, T; Ainsalu, K; Paap, P; Schmidt, J; Nikitina, N; Lutsar, I. (2009).\u00a0Absence of Genotypic Drug Resistance and Presence of Several Naturally Occurring Polymorphisms of Human Immunodeficiency Virus-1 CRF06_cpx in Treatment-Naive Patients in Estonia.\u00a0Journal of Medical Virology, 81(6), 953 \u2013 958.<\/a><\/span><\/p>\n

\n

2008<\/strong><\/span><\/p>\n

Bhaskarran, K.; Hamouda, O.; Sannes, M.;Bonfassa, F.; Johnson, A.M.; Lambert, P.C.; Porter, K.; CASCADE, Collaboration(2008).\u00a0Changes in the Risk of Death After HIV Seroconversion Compared With Mortality in the General Population.\u00a0JAMA: the journal of the American Medical Association, 300(1), 51 \u2013 59.<\/a><\/span><\/p>\n

Jarrin, I.; Geskus, R.; Bhaskaran, K.; Prins, M.; Perez-Hoyos, S.; Muga, R.; Hern\u00e1ndez-Aguado, I.; Meyer, L.; Porter, K.; del Amo, J.; Group author CASCADE Collaboration, (incl. I.Lutsar). (2008).\u00a0Gender differences in HIV progression to AIDS and death in industrialized countries: slower disease progression following HIV seroconversion in women.\u00a0American Journal of Epidemiology, 168(5), 532 \u2013 540.<\/span><\/p>\n

Touloumi, G.; Pantazis, N.; Stirnadel, HA.;Walker, AS.; Boufassa, F.; Vanhems, P.; Porter, K. (2008).\u00a0Rates and determinants of virologic and immunological response to HAART resumption after treatment interruption in HIV-1 clinical practice.\u00a0Jaids-Journal of Acquired Immune Deficiency Syndromes, 49(5), 492 \u2013 498.<\/a><\/p>\n

\n

2005<\/strong><\/span><\/p>\n

Lutsar, I. (2005).<\/span>\u00a0HI-viirusinfektsioon kui globaalne probleem.\u00a0Eesti Arst,4, 238 \u2013 243.<\/a><\/span><\/p>\n","protected":false},"excerpt":{"rendered":"

2017 Huik, Kristi; Soodla, Pilleriin; Pauskar, Merit; Rajasaar, Heli; J\u00f5geda, Ene-Ly; Eveli, Kallas; Avi, Radko; Lutsar, Irja\u00a0The evalation of two HIV-1 incidence assays in subjects infected with\u00a0non-B subtype viruses.\u00a0ECCMID\u00a02017 2016 Laisaar, Kaja-Triin; Raag, Mait; Lutsar, Irja; Uusk\u00fcla, Anneli\u00a0People living with …<\/p>\n","protected":false},"author":128,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"class_list":["post-39","page","type-page","status-publish","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/sisu.ut.ee\/hiv\/wp-json\/wp\/v2\/pages\/39","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/sisu.ut.ee\/hiv\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/sisu.ut.ee\/hiv\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/sisu.ut.ee\/hiv\/wp-json\/wp\/v2\/users\/128"}],"replies":[{"embeddable":true,"href":"https:\/\/sisu.ut.ee\/hiv\/wp-json\/wp\/v2\/comments?post=39"}],"version-history":[{"count":1,"href":"https:\/\/sisu.ut.ee\/hiv\/wp-json\/wp\/v2\/pages\/39\/revisions"}],"predecessor-version":[{"id":157,"href":"https:\/\/sisu.ut.ee\/hiv\/wp-json\/wp\/v2\/pages\/39\/revisions\/157"}],"wp:attachment":[{"href":"https:\/\/sisu.ut.ee\/hiv\/wp-json\/wp\/v2\/media?parent=39"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}